Literature DB >> 21649868

Intravitreal bevacizumab (avastin) combined with vitrectomy for recurrences of proliferative vitreoretinopathy in Von Hippel-Lindau disease.

Ryotaro Tano, Keigo Kakurai, Toshiya Sakurai, Ritsuko Fujiwara, Tomiya Mano, Takatoshi Maeno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21649868     DOI： 10.1111/j.1755-3768.2011.02108.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  2 in total

1.  Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment.

Authors:  Ramya Appanraj; Hema Duraiswamy; Veerappan Saravanan; George Manayath; Narendran Venkatapathy
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

Review 2.  Von Hippel-Lindau Disease: Current Challenges and Future Prospects.

Authors:  Sven Gläsker; Evelynn Vergauwen; Christian A Koch; Alexander Kutikov; Alexander O Vortmeyer
Journal:  Onco Targets Ther       Date:  2020-06-16       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.